Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience

Rheumatol Int. 2015 Sep;35(9):1569-70. doi: 10.1007/s00296-015-3243-z. Epub 2015 Mar 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antirheumatic Agents / administration & dosage*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / diagnosis
  • Arthritis, Rheumatoid / drug therapy*
  • Humans
  • Remission Induction
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • tocilizumab